Pharmamel
Developing skincare products with melatonina and CoQ10 for facial regeneration and intensive cellular repair, and researching melatonina injections to prevent mortality in COVID-19 hospitalized patients.
Launch date
Employees
Market cap
-
Enterprise valuation
$34m (Public information from May 2023)
Company register number B13735246
Granada Andalusia (HQ)
Authorizing premium user...